{"organizations": [], "uuid": "0f24957363c31ab018363188d46f5c4fb0e86175", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180307.html", "section_title": "Archive News &amp; Video for Wednesday, 07 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-veloxis-submits-application-to-fda/brief-veloxis-submits-application-to-fda-seeking-new-indication-for-envarsus-xr-idUSFWN1QP0U1", "country": "US", "domain_rank": 408, "title": "BRIEF-Veloxis ‍submits application to FDA seeking new indication for Envarsus XR​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.183, "site_type": "news", "published": "2018-03-08T09:11:00.000+02:00", "replies_count": 0, "uuid": "0f24957363c31ab018363188d46f5c4fb0e86175"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-veloxis-submits-application-to-fda/brief-veloxis-submits-application-to-fda-seeking-new-indication-for-envarsus-xr-idUSFWN1QP0U1", "ord_in_thread": 0, "title": "BRIEF-Veloxis ‍submits application to FDA seeking new indication for Envarsus XR​", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 7 (Reuters) - Veloxis Pharmaceuticals A/S:\n* VELOXIS PHARMACEUTICALS - ‍SUBMITTED SUPPLEMENTAL NEW DRUG APPLICATION TO U.S. FOOD & DRUG ADMINISTRATION SEEKING A NEW INDICATION FOR ENVARSUS XR​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-08T09:11:00.000+02:00", "crawled": "2018-03-08T17:34:41.012+02:00", "highlightTitle": ""}